health

Cancer patients at NHS trust harmed by years of unnecessary chemotherapy, report finds

Cancer patients at NHS trust harmed by years of unnecessary chemotherapy, report finds

Trust apologises after findings on treatment of 20 brain tumour patients under oncologist who retired in 2023 Cancer patients were severely harmed after being given years of unnecessary chemotherapy treatment by an NHS trust, a report has found. Some people were misdiagnosed and given inappropriate courses of treatment, while others were incorrectly told that if they stopped chemotherapy they would die, according to a Royal College of Physicians (RCP) report.

Trust apologises after findings on treatment of 20 brain tumour patients under oncologist who retired in 2023

Cancer patients were severely harmed after being given years of unnecessary chemotherapy treatment by an NHS trust, a report has found.

Some people were misdiagnosed and given inappropriate courses of treatment, while others were incorrectly told that if they stopped chemotherapy they would die, according to a Royal College of Physicians (RCP) report.

The report on the treatment of brain tumour patients at University Hospitals Coventry and Warwickshire NHS trust was commissioned after concerns were raised by colleagues of Prof Ian Brown, a clinical oncologist, whose patients were handed over after his retirement in 2023.

They found that his patients were on long-term repeated cycles of the chemotherapy drug temozolomide (TMZ), which is far longer than the usual course of treatment, without evidence that continuing it would benefit them. Some of his patients had been left on treatment despite their cancer progressing, when moving to supportive care for their symptoms would have been a better choice.

The report examined the cases of 20 patients. Fifteen of these were found to have received unsatisfactory care and five cases were graded as requiring improvement.

One patient had more than 10 years of chemotherapy and was told they had deadly glioblastoma, according to the report. This was later found to be a grade-1 pilocytic astrocytoma, a low-grade tumour with potentially normal life expectancy that does not require chemotherapy.

Another patient had chemotherapy treatment for a decade and experienced “significant toxicity”, including fatigue, nausea, severe shingles requiring hospital admission, and nausea and vomiting.

Leaders at the trust have apologised for the failures. The legal firm Brabners, which is representing more than 40 patients, is calling for an independent public inquiry.

The report says the trust should ensure that all living patients treated with more than 12 cycles of TMZ have had their case independently reviewed.

Becky Jones received more than 100 cycles of chemotherapy over a 10-year period after she was incorrectly diagnosed with a grade-4 glioblastoma and told she had between six and 12 months to live.

“For years, I questioned why I was still being given chemotherapy when my scans were stable, but I was repeatedly told that without it I would die,” Jones said.

She said seeing the report independently confirm the serious failings that had occurred was “validating” but it was “incredibly painful” to see how many opportunities there had been for the patients’ care to be reviewed. “I now need a full and honest explanation of what happened to me,” Jones said.

Prof Andy Hardy, the trust’s chief executive, and Sue Noyes, its chair, said they were “deeply sorry to all the patients and families affected by failures within our neuro-oncology service under the care of retired clinical oncologist Ian Brown”.

They said: “We recognise the concern, distress and loss of trust experienced by those who placed their faith in us during some of the most difficult moments of their lives. While an apology alone cannot undo the issues experienced, we are clear that meaningful action is being taken.

“These findings make for extremely difficult reading and raise serious questions about individual clinical decisions and historical governance. We will learn from this openly, transparently and with the utmost urgency.

  • trust
  • chemotherapy
  • report
  • cancer
  • nhs
  • patient
  • treatment
  • apologise

Summaries and tags are generated automatically. Stay informed with VidiaNews.

Related news

‘Deeply concerning’: NHS in England reports more than 3,000 incidents of staff snooping on patients’ records
health

‘Deeply concerning’: NHS in England reports more than 3,000 incidents of staff snooping on patients’ records

Campaign groups and regulators say data breaches are distressing for patients and families and erode trust in the health service The NHS in England has recorded more than 3,000 incidents of staff inappropriately snooping on patients’ medical records in the last five years. A lack of transparency from NHS organisations after data breaches were uncovered further compounded the heartache, they added.

Read →
Bacterial toxin produced by E coli leading suspect in rise in bowel cancer among under-50s
health

Bacterial toxin produced by E coli leading suspect in rise in bowel cancer among under-50s

Scientists tell Commons committee that exposure to colibactin in early life is a potential driver of early onset colorectal cancer Exposure to a bacterial toxin in early life has emerged as a leading suspect in the rise of bowel cancer amongs those under 50, MPs have heard. Cases of early onset bowel cancer have doubled in many countries in the past two decades, and while rising obesity and a fall in physical activity are contributors, researchers believe other factors must also be involved.

Read →
Doctor whose evidence helped to convict Lucy Letby was barred from treating patients during trial
health

Doctor whose evidence helped to convict Lucy Letby was barred from treating patients during trial

Exclusive: Jury was never told that Prof Peter Hindmarsh was barred from practising over concerns for patients’ safety A senior doctor whose evidence helped to convict Lucy Letby and who was held up by prosecutors as a pre-eminent expert was barred from treating patients during the trial over fears he posed a risk to their safety. Prof Peter Hindmarsh, a specialist in hormones in children, was crucial to the crown’s argument that Letby had poisoned children by injecting insulin into fluid bags.

Read →